SHORT-TERM CHANGES OF SERUM POTASSIUM CONCENTRATION INDUCED BY PHYSICAL EXERCISE IN PATIENTS WITH ARTERIAL HYPERTENSION TREATED WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ALONE OR IN COMBINATION WITH STATIN

被引:0
|
作者
Deska, P. [1 ]
Nowicki, M. [2 ]
机构
[1] Dept Internal Med Dist Hosp, Klobuck, Poland
[2] Med Univ Lodz, Dept Nephrol Hypertens & Kidney Transplantat, 251 Pomorska St, PL-92213 Lodz, Poland
来源
关键词
hyperkalemia; physical exercise; arterial hypertension; angiotensin-converting enzyme inhibitor; hydroxy-methyl-glutaryl-coenzyme A; reductase inhibitor; RHABDOMYOLYSIS; HYPERKALEMIA; MANAGEMENT; HYDRATION; WINGATE; TIME;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Intensive physical exercise may facilitate potassium release from skeletal muscles that may result in hyperkalemia. Commonly used drugs including angiotensin converting enzyme inhibitors (ACEI) and statins increase a risk of hyperkalemia. It is not known whether the effect of these drugs on serum potassium during physical exercise is additive. The study compared the effect of physical exercise on the changes of serum potassium in hypertensive patients receiving ACEI alone or in combination with statin. Eighteen patients with arterial hypertension with normal renal function were included in a prospective placebo-controlled cross-over study. The patients underwent 3 exercise tests on a bicycle ergometer with 55 - 60% of maximum oxygen consumption each lasting 30 minutes, i.e. after being treated with ACEI alone for six months, and then in a random order after the administration of ACEI with statin or ACEI with placebo each time for eight weeks separated by 2-week wash-out. Serum potassium was measured with atomic emission flame spectrometry before and after 15 and 30 minutes exercise and after 30-minute recovery. During the exercise serum potassium concentration increased moderately but significantly during all exercise tests. Mean serum potassium during exercise remained within the normal range. There were no differences in the exercise-induced changes of serum potassium during the exercise tests performed after ACEI combined with statin or with placebo. Addition of statin to ACEI does not increase the risk of hyperkalemia in hypertensive patients with preserved renal function during physical exercise with intensity typical for routine daily activities.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 50 条
  • [21] ANALYSIS OF BIOLOGICAL, STRUCTURAL AND FUNCTIONAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION, TREATED WITH ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS
    Andor, M.
    Buda, V.
    Cristescu, C.
    Voicu, M.
    Suciu, L.
    Muntean, C.
    Tomescu, M.
    ATHEROSCLEROSIS, 2016, 252 : E51 - E51
  • [22] Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor
    Kinugawa, T
    Ogino, K
    Kato, M
    Furuse, Y
    Shimoyama, M
    Mori, M
    Endo, A
    Kato, T
    Omodani, H
    Osaki, S
    Miyakoda, H
    Hisatome, I
    Shigemasa, C
    GENERAL PHARMACOLOGY, 1998, 31 (01): : 93 - 99
  • [23] Short-term results in patients with acute heart failure under treatment with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Haro Bosch, A.
    Cabello Zamora, I
    Fuentes Gonzalez, L.
    Lopez Delmas, N.
    Jacob Rodriguez, J.
    Malchair, P.
    EMERGENCIAS, 2023, 35 (03): : 235 - 236
  • [24] Treatment with angiotensin-converting enzyme inhibitors is associated with a reduction in short-term mortality in older patients with acute ischemic stroke
    Zuliani, G
    Cherubini, A
    Volpato, S
    Atti, AR
    Blè, A
    Vavalle, C
    Di Todaro, F
    Benedetti, C
    Ruggiero, C
    Senin, U
    Fellin, R
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2005, 60 (04): : 463 - 465
  • [25] The Angiotensin-Converting Enzyme I/D Polymorphism and Exercise-Induced Changes in Physical Function among Caucasian Older Adults
    Buford, Thomas W.
    Hsu, Fang-Chi
    Brinkley, Tina E.
    Carter, Christy S.
    Church, Timothy S.
    Dodson, John A.
    Goodpaster, Bret H.
    McDermott, Mary M.
    Nicklas, Barbara J.
    Yank, Veronica
    Johnson, Julie A.
    Pahor, Marco
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2014, 46 (05): : 598 - 598
  • [26] THE USE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CAPTOPRYL AND PERIPHERAL VASODILATOR MINOXIDIL IN THE TREATMENT OF PATIENTS WITH STABLE AND MALIGNANT ARTERIAL-HYPERTENSION
    ARABIDZE, GG
    LESCHINSKY, PM
    LORDKIPANIDZE, NL
    KUTSENKO, AI
    MASENKO, VP
    VOLKOV, VN
    SAVELIEV, VY
    BRONSHTEIN, RI
    KARDIOLOGIYA, 1983, 23 (12) : 24 - 28
  • [27] EFFECTS OF FOSENOPRIL, A ONCE-DAILY ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ON RESTING AND EXERCISE-INDUCED CHANGES OF BLOOD-PRESSURE, HORMONAL VARIABLES, AND PLASMA POTASSIUM IN ESSENTIAL-HYPERTENSION
    SULLIVAN, PA
    DINEEN, M
    CERVENKA, J
    OCONNOR, DT
    AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (03) : S280 - S283
  • [28] Comparison of Effects of Low Dose of Spironolactone and a Thiazide Diuretic in Patients with Hypertension Treated with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Type 1 Receptor Blocker
    Yutaka, Miyashita
    Mifune, Mizuo
    Kubota, Eiji
    Itoh, Hiroshi
    Saito, Ikuo
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2009, 31 (08) : 648 - 656
  • [29] Oxidative stress-associated hypertension in surgically induced brain injury patients: Effects of β-blocker and angiotensin-converting enzyme inhibitor
    Velayutham, Parthiban K.
    Das Adhikary, Sanjib
    Babu, Srinivasa K.
    Vedantam, Rajshekhar
    Korula, Grace
    Ramachandran, Anup
    JOURNAL OF SURGICAL RESEARCH, 2013, 179 (01) : 125 - 131
  • [30] Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure
    T. Kinugawa
    M. Kato
    M. Mori
    A. Endo
    T. Kato
    T. Hamada
    N. Noguchi
    H. Omodani
    S. Osaki
    K. Ogino
    H. Miyakoda
    I. Hisatome
    C. Shigemasa
    European Journal of Clinical Pharmacology, 1998, 54 : 209 - 214